KBC Group NV
KBC Group NV (KBCSY) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for KBC Group NV (KBCSY), featuring income statements, balance sheets, and cash flow data.
KBC Group NV (KBCSY) Income Statement & Financial Overview
Review KBC Group NV KBCSY income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $5.90B | $6.06B | $6.29B | $2.74B |
| Cost of Revenue | $3.00B | $3.19B | $3.51B | $4.07B |
| Gross Profit | $2.90B | $2.78B | $2.73B | -$1.33B |
| Gross Profit Ratio | $0.49 | $0.46 | $0.43 | -$0.49 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $318.00M | $419.00M | $355.00M | $302.00M |
| Operating Expenses | $2.15B | $1.76B | $2.78B | $82.00M |
| Total Costs & Expenses | $5.15B | $5.04B | $5.21B | $82.00M |
| Interest Income | $4.42B | $4.62B | $4.90B | $5.10B |
| Interest Expense | $3.00B | $3.19B | $3.51B | $3.72B |
| Depreciation & Amortization | $99.00M | $100.00M | $97.00M | $93.00M |
| EBITDA | $846.00M | $1.12B | $1.18B | $1.25B |
| EBITDA Ratio | $0.14 | $0.18 | $0.19 | $0.46 |
| Operating Income | $747.00M | $1.11B | $0.00 | $2.65B |
| Operating Income Ratio | $0.13 | $0.18 | $0.00 | $0.97 |
| Other Income/Expenses (Net) | $0.00 | -$93.00M | $1.08B | -$1.50B |
| Income Before Tax | $747.00M | $1.02B | $1.08B | $1.16B |
| Income Before Tax Ratio | $0.13 | $0.17 | $0.17 | $0.42 |
| Income Tax Expense | $202.00M | -$96.00M | $211.00M | $237.00M |
| Net Income | $546.00M | $1.12B | $868.00M | $925.00M |
| Net Income Ratio | $0.09 | $0.18 | $0.14 | $0.34 |
| EPS | $1.32 | $2.75 | $2.14 | $2.25 |
| Diluted EPS | $1.32 | $2.75 | $2.14 | $2.25 |
| Weighted Avg Shares Outstanding | $397.00M | $405.82M | $405.61M | $411.11M |
| Weighted Avg Shares Outstanding (Diluted) | $397.00M | $405.82M | $405.61M | $411.11M |
Over the past four quarters, KBC Group NV demonstrated steady revenue growth, increasing from $2.74B in Q2 2024 to $5.90B in Q1 2025. Operating income reached $747.00M in Q1 2025, maintaining a consistent 13% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $846.00M, reflecting operational efficiency. Net income dropped to $546.00M, with EPS at $1.32. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan